Skip to main content
Fig. 3 | Journal of Inflammation

Fig. 3

From: Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion

Fig. 3

Correlation between the change of the aqueous flare value and improvement of BCVA or CMT at 6 months after intravitreal ranibizumab injection (IRI). a There was a significant positive correlation between the change of the aqueous flare value and improvement of BCVA at 6 months after IRI (ρ = 0.45, P = 0.047). b There was also a significant positive correlation between the change of the aqueous flare value and improvement of CMT at 6 months after IRI (ρ = 0.47, P = 0.038)

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us